Bullfrog AI, Inc. Warrants Stock (NASDAQ:BFRG)


Chart

Previous Close

$1.64

52W Range

$1.35 - $4.84

50D Avg

$2.28

200D Avg

$2.36

Market Cap

$13.28M

Avg Vol (3M)

$862.02K

Beta

0.79

Div Yield

-

BFRG Company Profile


BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Feb 13, 2023

Website

BFRG Performance


Peer Comparison


TickerCompany
MGRXMangoceuticals, Inc.
ETAOETAO International Co., Ltd.